These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 23557964)
1. Fused in sarcoma (FUS): an oncogene goes awry in neurodegeneration. Dormann D; Haass C Mol Cell Neurosci; 2013 Sep; 56():475-86. PubMed ID: 23557964 [TBL] [Abstract][Full Text] [Related]
2. Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations. Neumann M; Valori CF; Ansorge O; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ishihara K; Ang LC; Bilbao JM; Mackenzie IR Acta Neuropathol; 2012 Nov; 124(5):705-16. PubMed ID: 22842875 [TBL] [Abstract][Full Text] [Related]
3. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Neumann M; Bentmann E; Dormann D; Jawaid A; DeJesus-Hernandez M; Ansorge O; Roeber S; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ang LC; Bilbao J; Rademakers R; Haass C; Mackenzie IR Brain; 2011 Sep; 134(Pt 9):2595-609. PubMed ID: 21856723 [TBL] [Abstract][Full Text] [Related]
4. Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS. Dormann D; Madl T; Valori CF; Bentmann E; Tahirovic S; Abou-Ajram C; Kremmer E; Ansorge O; Mackenzie IR; Neumann M; Haass C EMBO J; 2012 Nov; 31(22):4258-75. PubMed ID: 22968170 [TBL] [Abstract][Full Text] [Related]
5. FUS is phosphorylated by DNA-PK and accumulates in the cytoplasm after DNA damage. Deng Q; Holler CJ; Taylor G; Hudson KF; Watkins W; Gearing M; Ito D; Murray ME; Dickson DW; Seyfried NT; Kukar T J Neurosci; 2014 Jun; 34(23):7802-13. PubMed ID: 24899704 [TBL] [Abstract][Full Text] [Related]
6. Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS. Suárez-Calvet M; Neumann M; Arzberger T; Abou-Ajram C; Funk E; Hartmann H; Edbauer D; Kremmer E; Göbl C; Resch M; Bourgeois B; Madl T; Reber S; Jutzi D; Ruepp MD; Mackenzie IR; Ansorge O; Dormann D; Haass C Acta Neuropathol; 2016 Apr; 131(4):587-604. PubMed ID: 26895297 [TBL] [Abstract][Full Text] [Related]
7. Transportin 1 colocalization with Fused in Sarcoma (FUS) inclusions is not characteristic for amyotrophic lateral sclerosis-FUS confirming disrupted nuclear import of mutant FUS and distinguishing it from frontotemporal lobar degeneration with FUS inclusions. Troakes C; Hortobágyi T; Vance C; Al-Sarraj S; Rogelj B; Shaw CE Neuropathol Appl Neurobiol; 2013 Aug; 39(5):553-61. PubMed ID: 22934812 [TBL] [Abstract][Full Text] [Related]
8. FET proteins in frontotemporal dementia and amyotrophic lateral sclerosis. Mackenzie IR; Neumann M Brain Res; 2012 Jun; 1462():40-3. PubMed ID: 22261247 [TBL] [Abstract][Full Text] [Related]
9. Stress granules in neurodegeneration--lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma. Bentmann E; Haass C; Dormann D FEBS J; 2013 Sep; 280(18):4348-70. PubMed ID: 23587065 [TBL] [Abstract][Full Text] [Related]
10. Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences. Neumann M Rev Neurol (Paris); 2013 Oct; 169(10):793-8. PubMed ID: 24011641 [TBL] [Abstract][Full Text] [Related]
11. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other? Baloh RH Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957 [TBL] [Abstract][Full Text] [Related]
12. Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS. Ito D; Suzuki N Neurology; 2011 Oct; 77(17):1636-43. PubMed ID: 21956718 [TBL] [Abstract][Full Text] [Related]
13. TDP-43 and FUS: a nuclear affair. Dormann D; Haass C Trends Neurosci; 2011 Jul; 34(7):339-48. PubMed ID: 21700347 [TBL] [Abstract][Full Text] [Related]
16. FUS-mediated alternative splicing in the nervous system: consequences for ALS and FTLD. Orozco D; Edbauer D J Mol Med (Berl); 2013 Dec; 91(12):1343-54. PubMed ID: 23974990 [TBL] [Abstract][Full Text] [Related]
17. Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43). Bentmann E; Neumann M; Tahirovic S; Rodde R; Dormann D; Haass C J Biol Chem; 2012 Jun; 287(27):23079-94. PubMed ID: 22563080 [TBL] [Abstract][Full Text] [Related]
18. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. Ratti A; Buratti E J Neurochem; 2016 Aug; 138 Suppl 1():95-111. PubMed ID: 27015757 [TBL] [Abstract][Full Text] [Related]
19. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis. Verbeeck C; Deng Q; Dejesus-Hernandez M; Taylor G; Ceballos-Diaz C; Kocerha J; Golde T; Das P; Rademakers R; Dickson DW; Kukar T Mol Neurodegener; 2012 Oct; 7():53. PubMed ID: 23046583 [TBL] [Abstract][Full Text] [Related]